Egypt to build 5 factories for pharmaceutical raw materials

HOLDIPHARMA is aiming to establish five new factories in partnership with the private sector, with EGP 2.5 billion in investments, Asharq Business reported on March 28th, citing three unnamed sources familiar with the matter.

The yet-to-be-established factories would produce up to 100 pharmaceutical raw items until 2025.

The move aims at meeting up to 20% of the market’s needs for pharmaceutical raw materials to reduce import expenditure.

One of the sources revealed that El-Nasr Pharmaceutical Chemicals Company, affiliated to HOLDIPHARMA, is currently finalizing procedures of building the five factories in cooperation with private pharmaceutical companies, with production capacities of up to 70 tons per year for each factory.

HOLDIPHARMA will soon sign a contract with the largest Indian company for the manufacture of pharmaceutical raw materials, according to another source.